東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Role of protein kinase C isoforms in...

McCracken, Meredith Ann.

Linked to FindBook

Google Book

Amazon

博客來

Role of protein kinase C isoforms in human breast tumor cell survival.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Role of protein kinase C isoforms in human breast tumor cell survival./
Author:	McCracken, Meredith Ann.
Description:	162 p.
Notes:	Chair: Jeannine Strobl.
Contained By:	Dissertation Abstracts International63-06B.
Subject:	Biology, Genetics. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3055933
ISBN:	0493710809

Role of protein kinase C isoforms in human breast tumor cell survival.
McCracken, Meredith Ann.

Role of protein kinase C isoforms in human breast tumor cell survival. - 162 p.

Chair: Jeannine Strobl.

Thesis (Ph.D.)--West Virginia University, 2002.

Protein kinase C (PKC) is a family of serine/threonine kinases composed of 12 unique isoforms that function in a variety of cellular processes including proliferation, apoptosis, differentiation and carcinogenesis. The contribution of individual PKC isoforms to these processes is largely unexplored. The purpose of this study is to identify specific PKC isoforms that promote breast tumor cell survival following radiation treatment. This work demonstrated that depletion of PKC delta and PKC zeta isoforms from MCF-7 and MDA-MB-231 human breast tumor cells by antisense oligonucleotides significantly impaired survival following radiation insult. Antisense oligonucleotides were shown to be effective and selective inhibitors of specific PKC isoforms. The PKC delta inhibitor, rottlerin reduced cell survival and confirmed that PKC delta inhibition attenuates breast tumor cell survival, both in the presence and absence of radiation insult. Inhibition of PKC zeta significantly reduced the survival of radiation treated breast tumor cells. DNA damage, assessed using the comet assay provided evidence that depletion of PKC delta from MDA-MB-231 cells results in loss of DNA integrity. In contrast, PKC zeta antisense oligonucleotide treatment did not result in DNA damage. Consistent with participation in cell survival, PKC delta protein levels were elevated in response to radiation treatment. These studies have identified two PKC isoforms that function in breast tumor cell survival and support the application of isoform specific PKC inhibitors to the treatment of human breast tumors.

ISBN: 0493710809Subjects--Topical Terms:

1017730
Biology, Genetics.

Role of protein kinase C isoforms in human breast tumor cell survival.
LDR:02465nam 2200277 a 45 001 927518
005 20110425
008 110425s2002 eng d
020 $a 0493710809
035 $a (UnM)AAI3055933
035 $a AAI3055933
040 $a UnM $c UnM
100 1 $a McCracken, Meredith Ann. $3 1251079
245 1 0 $a Role of protein kinase C isoforms in human breast tumor cell survival.
300 $a 162 p.
500 $a Chair: Jeannine Strobl.
500 $a Source: Dissertation Abstracts International, Volume: 63-06, Section: B, page: 2706.
502 $a Thesis (Ph.D.)--West Virginia University, 2002.
520 $a Protein kinase C (PKC) is a family of serine/threonine kinases composed of 12 unique isoforms that function in a variety of cellular processes including proliferation, apoptosis, differentiation and carcinogenesis. The contribution of individual PKC isoforms to these processes is largely unexplored. The purpose of this study is to identify specific PKC isoforms that promote breast tumor cell survival following radiation treatment. This work demonstrated that depletion of PKC delta and PKC zeta isoforms from MCF-7 and MDA-MB-231 human breast tumor cells by antisense oligonucleotides significantly impaired survival following radiation insult. Antisense oligonucleotides were shown to be effective and selective inhibitors of specific PKC isoforms. The PKC delta inhibitor, rottlerin reduced cell survival and confirmed that PKC delta inhibition attenuates breast tumor cell survival, both in the presence and absence of radiation insult. Inhibition of PKC zeta significantly reduced the survival of radiation treated breast tumor cells. DNA damage, assessed using the comet assay provided evidence that depletion of PKC delta from MDA-MB-231 cells results in loss of DNA integrity. In contrast, PKC zeta antisense oligonucleotide treatment did not result in DNA damage. Consistent with participation in cell survival, PKC delta protein levels were elevated in response to radiation treatment. These studies have identified two PKC isoforms that function in breast tumor cell survival and support the application of isoform specific PKC inhibitors to the treatment of human breast tumors.
590 $a School code: 0256.
650 4 $a Biology, Genetics. $3 1017730
650 4 $a Health Sciences, Oncology. $3 1018566
690 $a 0369
690 $a 0992
710 2 0 $a West Virginia University. $3 1017532
773 0 $t Dissertation Abstracts International $g 63-06B.
790 $a 0256
790 1 0 $a Strobl, Jeannine, $e advisor
791 $a Ph.D.
792 $a 2002
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3055933